Abstract
An overview of psychopharmacological interventions in developmental disorders is presented, followed by a review of treatment in fragile X syndrome, fetal alcohol syndrome, Angelman syndrome, Prader-Willi syndrome, Smith-Magenis syndrome, and velocardiofacial syndrome. Each of these disorders has a specific behavioral phenotype, and we are making progress in clarifying each of their psychopharmacological phenotypes. Common problems such as attention deficit hyperactivity disorder and mood lability are reviewed, although unique aspects of each disorder are emphasized.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 305-313 |
| Number of pages | 9 |
| Journal | Mental Retardation and Developmental Disabilities Research Reviews |
| Volume | 5 |
| Issue number | 4 |
| DOIs | |
| State | Published - 1999 |
| Externally published | Yes |
Keywords
- ADHD
- Angelman syndrome
- Fetal alcohol syndrome
- Fragile X syndrome
- Mental retardation
- Prader-Willi syndrome
- Psychopharmacology
- Smith-Magenis syndrome
- Stimulants
- Velocardiofacial syndrome
- Williams syndrome
ASJC Scopus subject areas
- Genetics(clinical)
- Pediatrics, Perinatology, and Child Health
- Neuropsychology and Physiological Psychology
Fingerprint Dive into the research topics of 'Psychopharmacological interventions in fragile X syndrome, fetal alcohol syndrome, Prader-Willi syndrome, Angelman syndrome, Smith Magenis syndrome, and velocardiofacial syndrome'. Together they form a unique fingerprint.
Cite this
Hagerman, R. J. (1999). Psychopharmacological interventions in fragile X syndrome, fetal alcohol syndrome, Prader-Willi syndrome, Angelman syndrome, Smith Magenis syndrome, and velocardiofacial syndrome. Mental Retardation and Developmental Disabilities Research Reviews, 5(4), 305-313. https://doi.org/10.1002/(SICI)1098-2779(1999)5:4<305::AID-MRDD8>3.0.CO;2-L